Publication | Closed Access

Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice

InflammationImiquimod-induced Psoriasiform InflammationCytokineAutoimmune DiseaseMedicineT-regulatory CellImmunologyRegulatory T CellsAutoimmunityTreg CellsDermatologyInterleukin-2-inducible T-cell KinaseImmunotherapyPsoriatic ArthritisCell Signaling